Status Epilepticus
|
0.500 |
Biomarker
|
disease |
CTD_human |
The onset of SE was accompanied by activation of Src-family tyrosine kinases and Pyk2 in the post-synaptic density, consistent with a role for these enzymes in SE-induced tyrosine phosphorylation.
|
16600505 |
2006 |
Status Epilepticus
|
0.500 |
Biomarker
|
disease |
RGD |
The onset of SE was accompanied by activation of Src-family tyrosine kinases and Pyk2 in the post-synaptic density, consistent with a role for these enzymes in SE-induced tyrosine phosphorylation.
|
16600505 |
2006 |
melanoma
|
0.340 |
Biomarker
|
disease |
BEFREE |
This review discusses the role MAPK and Phosphatidylinositol-3-kinase-protein kinase B-mammalian target of rapamycin (PI3K-AKT-mTOR) pathways play in the mechanism of resistance of melanomas.
|
28708099 |
2017 |
melanoma
|
0.340 |
Biomarker
|
disease |
BEFREE |
We found ERBB4 mutations in 19% of individuals with melanoma and found mutations in two other kinases (FLT1 and PTK2B) in 10% of individuals with melanomas.
|
19718025 |
2009 |
melanoma
|
0.340 |
Biomarker
|
disease |
CTD_human |
We found ERBB4 mutations in 19% of individuals with melanoma and found mutations in two other kinases (FLT1 and PTK2B) in 10% of individuals with melanomas.
|
19718025 |
2009 |
melanoma
|
0.340 |
AlteredExpression
|
disease |
BEFREE |
Constitutive activation of Akt/protein kinase B in melanoma leads to up-regulation of nuclear factor-kappaB and tumor progression.
|
12499277 |
2002 |
melanoma
|
0.340 |
GeneticVariation
|
disease |
BEFREE |
Thus in human melanoma PH domain mutations of PKB/Akt do not play a major role in melanoma carcinogenesis.
|
11828257 |
2002 |
Skin Neoplasms
|
0.310 |
Biomarker
|
group |
CTD_human |
Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4.
|
19718025 |
2009 |
Alcoholic Intoxication, Chronic
|
0.310 |
Biomarker
|
disease |
PSYGENET |
Our results indicate a possible association of alcohol dependence with a genotype of the SNP T137346C of the PTK fyn, with C being the risk allele.
|
14675807 |
2003 |
Alcoholic Intoxication, Chronic
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
Our results indicate a possible association of alcohol dependence with a genotype of the SNP T137346C of the PTK fyn, with C being the risk allele.
|
14675807 |
2003 |
Skin Neoplasms
|
0.310 |
Biomarker
|
group |
BEFREE |
Mutations of the PH domain of protein kinase B (PKB/AKT) are absent in human epidermal skin tumors.
|
11752813 |
2001 |
Malignant neoplasm of skin
|
0.300 |
Biomarker
|
disease |
CTD_human |
Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4.
|
19718025 |
2009 |
Petit mal status
|
0.300 |
Biomarker
|
disease |
CTD_human |
Increase in tyrosine phosphorylation of the NMDA receptor following the induction of status epilepticus.
|
16600505 |
2006 |
Grand Mal Status Epilepticus
|
0.300 |
Biomarker
|
disease |
CTD_human |
Increase in tyrosine phosphorylation of the NMDA receptor following the induction of status epilepticus.
|
16600505 |
2006 |
Complex Partial Status Epilepticus
|
0.300 |
Biomarker
|
disease |
CTD_human |
Increase in tyrosine phosphorylation of the NMDA receptor following the induction of status epilepticus.
|
16600505 |
2006 |
Status Epilepticus, Subclinical
|
0.300 |
Biomarker
|
disease |
CTD_human |
Increase in tyrosine phosphorylation of the NMDA receptor following the induction of status epilepticus.
|
16600505 |
2006 |
Non-Convulsive Status Epilepticus
|
0.300 |
Biomarker
|
disease |
CTD_human |
Increase in tyrosine phosphorylation of the NMDA receptor following the induction of status epilepticus.
|
16600505 |
2006 |
Simple Partial Status Epilepticus
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Increase in tyrosine phosphorylation of the NMDA receptor following the induction of status epilepticus.
|
16600505 |
2006 |
Hypertensive disease
|
0.220 |
PosttranslationalModification
|
group |
BEFREE |
IMD could attenuate the vascular collagen remodeling caused by angiotensin II-induced hypertension via inhibiting phosphorylation of Akt and MAPK.
|
30229842 |
2018 |
Hypertensive disease
|
0.220 |
Biomarker
|
group |
RGD |
In the present study, we examined whether FAK and PYK2 are up-regulated by elevated blood pressure or circulating humoral factors in hypertension.
|
21068519 |
2010 |
Hypertensive disease
|
0.220 |
GeneticVariation
|
group |
LHGDN |
To examine the contribution of PTK2B, we sequenced the PTK2B gene using 48 patients with hypertension, identified 62 genetic polymorphisms, and genotyped six representative single nucleotide polymorphisms in population-based case-control samples from 3655 Japanese individuals (1520 patients with hypertension and 2135 controls).
|
18075463 |
2007 |
Left Ventricular Hypertrophy
|
0.210 |
Biomarker
|
disease |
BEFREE |
Transvenous endomyocardial biopsies were obtained in 52 hypertensive patients with left ventricular hypertrophy: 28 without heart failure and 24 with heart failure. gp130 and gp130-dependent antiapoptotic pathways p42/44 mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3 kinase (PI3K)/protein kinase B (Akt) as well as gp130 agonist cardiotrophin-1 were analyzed by reverse transcriptase-polymerase chain reaction and western blot.
|
17885560 |
2007 |
Left Ventricular Hypertrophy
|
0.210 |
Biomarker
|
disease |
RGD |
Furthermore, there was a high degree of correlation (R = 0.75; P < 0.001) between the level of PYK2 and the degree of LVH in 24-wk sham and banded animals.
|
12124218 |
2002 |
Alzheimer's Disease
|
0.200 |
Biomarker
|
disease |
BEFREE |
Alzheimer's Disease Risk Factor Pyk2 Mediates Amyloid-β-Induced Synaptic Dysfunction and Loss.
|
30518596 |
2019 |
Alzheimer's Disease
|
0.200 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.
|
30617256 |
2019 |